eye problems with semaglutide Ozempic Blindness: Should You Worry? Ophthalmologic Manifestations from Semaglutide (Ozempic/Wegovy)

The analysis focused on adults aged 18 years and older with type 2 diabetes mellitus who initiated one of the following treatments between December 2018 and December 2021: Semaglutide Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) Other glucose-lowering therapies Participants were followed through to December 2023

In my personal experience, I haven't encountered any significant negative side effects

Some people experience gastrointestinal side-effects including nausea, vomiting, constipation and diarrhea

Retatrutide uses three escalation steps (2mg to 4mg to 8mg to 12mg) over 12 to 16 weeks, while tirzepatide uses up to six steps (2.5mg through 15mg) over 16 to 24 weeks